Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Virgin Group Fund Elevates 23AndMe $3.5Bn IPO

Feb 07 2021

• By Marion Webb

Related Content

MTI Outlook 2020: Medtechs Enter The Decade Of Digital, Consumers and Wellness

Dec 16 2019

Blank Check Companies’ Hunt For Innovative Medtech Start-Ups To Heat Up Further, Experts Predict

Feb 02 2021

Top FDA Officials Warn About Non-Vetted Pharmacogenetic Tests After Latest 23andMe Approval

Nov 01 2018

OTC Diagnostics Forecast: Growing With Pandemic But High Bar For Approval Could Slow Spread

Dec 13 2020

Latest Home-Use COVID-19 Sample Collection Kit Authorized In US Is First Available OTC

Dec 11 2020

Related Companies

23andMe, Inc.

GSK plc

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window